In vitro assessment of selenium bioavailability from selenized lactic acid bacteria using a static INFOGEST digestion model and intestinal permeability model
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60461373%3A22340%2F25%3A43931434" target="_blank" >RIV/60461373:22340/25:43931434 - isvavai.cz</a>
Alternative codes found
RIV/60460709:41210/25:102118 RIV/26722861:_____/25:N0000002
Result on the web
<a href="https://doi.org/10.1016/j.jtemb.2025.127632" target="_blank" >https://doi.org/10.1016/j.jtemb.2025.127632</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.jtemb.2025.127632" target="_blank" >10.1016/j.jtemb.2025.127632</a>
Alternative languages
Result language
angličtina
Original language name
In vitro assessment of selenium bioavailability from selenized lactic acid bacteria using a static INFOGEST digestion model and intestinal permeability model
Original language description
Background and objective: Microbial selenium (Se) supplementation is an essential area of biotechnologicalresearch due to differences in the bioavailability and toxicity of different forms of selenium. To date, research hasfocused mainly on the use of selenized yeast. However, in recent years, scientific interest has also increased inother microorganisms, such as lactic acid bacteria (LAB), which have several unique properties that can affect thequality and bioavailability of selenium. LAB, unlike yeast, can also act as probiotics, which may bring additionalhealth benefits related to improving the intestinal microbiota and supporting the health of the gastrointestinaltract.Methods: This study investigates the in vitro bioaccessibility and bioavailability of Se from two lactic acid bacterialstrains, Streptococcus thermophilus CCDM 144 and Enterococcus faecium CCDM 922 A. We evaluated Seaccumulation, speciation, and stability during simulated gastrointestinal digestion and Se permeation through aCaco-2 cell monolayer model.Results: Both strains accumulated Se, metabolizing it predominantly into selenium nanoparticles (SeNPs,64–77 % of total Se), with only a minor fraction (<5 % of total Se) of organic Se species. Experiments revealedthat while organic Se species had high bioavailability (up to 90 %), their bioaccessibility during digestion wasvery low (<0.1 % of total Se). In contrast, SeNPs showed high bioaccessibility (~90 %) and moderate transportefficiency through the intestinal model (16–19 % after 4 hours).Conclusion: These results highlight the potential of SeNPs produced by lactic acid bacteria as a bioaccessible formof Se for dietary supplementation. Further research is required to explore the behavior of SeNPs within thehuman body to fully understand how they can be used safely and effectively in nutrition or other applications.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10608 - Biochemistry and molecular biology
Result continuities
Project
<a href="/en/project/QK22010186" target="_blank" >QK22010186: Postbiotics, bacterial exopolysaccharides and new oligosaccharides for functional synbiotic fermented products</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
ISSN
0946-672X
e-ISSN
1878-3252
Volume of the periodical
88
Issue of the periodical within the volume
April 2025
Country of publishing house
NL - THE KINGDOM OF THE NETHERLANDS
Number of pages
9
Pages from-to
nestránkováno
UT code for WoS article
001445514400001
EID of the result in the Scopus database
2-s2.0-86000367372